Genovis AB (publ.) Future Growth

Future criteria checks 2/6

Genovis AB (publ.)'s earnings are forecast to decline at 5.2% per annum while its annual revenue is expected to grow at 23.6% per year. EPS is expected to grow by 25.6% per annum. Return on equity is forecast to be 17.8% in 3 years.

Key information

-5.2%

Earnings growth rate

25.6%

EPS growth rate

Life Sciences earnings growth34.6%
Revenue growth rate23.6%
Future return on equity17.8%
Analyst coverage

Low

Last updated15 Mar 2024

Recent future growth updates

Recent updates

Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?

Mar 18
Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?

What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash

Feb 28
What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash

We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings

Feb 22
We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings

These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts

Feb 20
These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts

Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be

Feb 04
Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be

Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors

Oct 06
Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors

Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?

Jun 22
Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?

What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?

May 13
What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?

Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?

Dec 22
Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?

Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?

Nov 14
Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?

If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity

Jul 08
If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity

Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?

Jun 01
Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?

Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%

May 10
Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%

One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically

Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?

Aug 09
Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?

What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?

Mar 27
What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?

How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?

Dec 30
How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?

Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?

Nov 23
Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?

Earnings and Revenue Growth Forecasts

OM:GENO - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262995351643
12/31/20252464641543
12/31/20241594130593
12/31/2023158625568N/A
9/30/2023158544053N/A
6/30/2023151574049N/A
3/31/2023142424247N/A
12/31/202210411-5-1N/A
9/30/2022119414043N/A
6/30/2022112364043N/A
3/31/2022111363741N/A
12/31/202194254146N/A
9/30/2021711136N/A
6/30/2021691217N/A
3/31/2021659-129N/A
12/31/2020616-174N/A
9/30/202054-3-167N/A
6/30/2020643-119N/A
3/31/202060649N/A
12/31/20196110813N/A
9/30/20195812710N/A
6/30/201943504N/A
3/31/201940123N/A
12/31/201835-2-3-1N/A
9/30/201831-4-4-2N/A
6/30/201827-6-6-5N/A
3/31/201824-7-10-9N/A
12/31/201723-8-10-8N/A
9/30/201721-9N/A-9N/A
6/30/201721-9N/A-11N/A
3/31/201720-14N/A-15N/A
12/31/201619-15N/A-16N/A
9/30/201617-16N/A-18N/A
6/30/201616-21N/A-18N/A
3/31/201614-18N/A-14N/A
12/31/201514-20N/A-16N/A
9/30/201513-25N/A-18N/A
6/30/201511-24N/A-20N/A
3/31/201510-23N/A-21N/A
12/31/201410-22N/A-22N/A
9/30/20148-20N/A-18N/A
6/30/201410-17N/A-17N/A
3/31/201411-16N/A-14N/A
12/31/201310-16N/A-12N/A
9/30/201310-19N/A-15N/A
6/30/20139-19N/A-15N/A
3/31/20138-20N/A-16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GENO's earnings are forecast to decline over the next 3 years (-5.2% per year).

Earnings vs Market: GENO's earnings are forecast to decline over the next 3 years (-5.2% per year).

High Growth Earnings: GENO's earnings are forecast to decline over the next 3 years.

Revenue vs Market: GENO's revenue (23.6% per year) is forecast to grow faster than the Swedish market (2.1% per year).

High Growth Revenue: GENO's revenue (23.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GENO's Return on Equity is forecast to be low in 3 years time (17.8%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.